Logo image of RDBX

REDBOX ENTERTAINMENT INC (RDBX) Stock Fundamental Analysis

NASDAQ:RDBX - Nasdaq - US75724T1034 - Common Stock - Currency: USD

1.65  -1.85 (-52.86%)

After market: 1.655 +0.01 (+0.3%)

Fundamental Rating

1

Taking everything into account, RDBX scores 1 out of 10 in our fundamental rating. RDBX was compared to 71 industry peers in the Entertainment industry. RDBX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RDBX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDBX had negative earnings in the past year.
RDBX Yearly Net Income VS EBIT VS OCF VS FCFRDBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 50M -50M 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA -33.02%
ROE N/A
ROIC -68.8%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDBX Yearly ROA, ROE, ROICRDBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 -1K -2K -3K -4K

1.3 Margins

Industry RankSector Rank
OM -56.07%
PM (TTM) -33.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RDBX Yearly Profit, Operating, Gross MarginsRDBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RDBX is destroying value.
Compared to 1 year ago, RDBX has more shares outstanding
The debt/assets ratio for RDBX is higher compared to a year ago.
RDBX Yearly Shares OutstandingRDBX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M 40M
RDBX Yearly Total Debt VS Total AssetsRDBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M 400M

2.2 Solvency

RDBX has an Altman-Z score of -2.63. This is a bad value and indicates that RDBX is not financially healthy and even has some risk of bankruptcy.
RDBX has a Debt/Equity ratio of -9.59. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -9.59
Debt/FCF N/A
Altman-Z -2.63
ROIC/WACC-8.31
WACC8.28%
RDBX Yearly LT Debt VS Equity VS FCFRDBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.44 indicates that RDBX may have some problems paying its short term obligations.
A Quick Ratio of 0.44 indicates that RDBX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
RDBX Yearly Current Assets VS Current LiabilitesRDBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

RDBX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.09%.
The Revenue for RDBX has decreased by -47.17% in the past year. This is quite bad
The Revenue for RDBX have been decreasing by -42.02% on average. This is quite bad
EPS 1Y (TTM)-131.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.44%
Revenue 1Y (TTM)-47.17%
Revenue growth 3Y-42.02%
Revenue growth 5YN/A
Sales Q2Q%-17.6%

3.2 Future

Based on estimates for the next years, RDBX will show a very strong growth in Earnings Per Share. The EPS will grow by 43.02% on average per year.
The Revenue is expected to grow by 52.49% on average over the next years. This is a very strong growth
EPS Next Y54.42%
EPS Next 2Y39.52%
EPS Next 3Y38.39%
EPS Next 5Y43.02%
Revenue Next Year34.49%
Revenue Next 2Y51.76%
Revenue Next 3Y49.66%
Revenue Next 5Y52.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RDBX Yearly Revenue VS EstimatesRDBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
RDBX Yearly EPS VS EstimatesRDBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDBX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDBX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDBX Price Earnings VS Forward Price EarningsRDBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -4.16
RDBX Per share dataRDBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

RDBX's earnings are expected to grow with 38.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.52%
EPS Next 3Y38.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RDBX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REDBOX ENTERTAINMENT INC

NASDAQ:RDBX (8/10/2022, 8:09:16 PM)

After market: 1.655 +0.01 (+0.3%)

1.65

-1.85 (-52.86%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13 2022-05-13/amc
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner Change0%
Ins Owners4.26%
Ins Owner Change0%
Market Cap22.58M
Analysts45
Price Target2.21 (33.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-0.24%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -4.16
EPS(TTM)-9.33
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS25.7
BVpS-2.3
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.02%
ROE N/A
ROCE N/A
ROIC -68.8%
ROICexc N/A
ROICexgc 441.92%
OM -56.07%
PM (TTM) -33.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity -9.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -2.63
F-Score2
WACC8.28%
ROIC/WACC-8.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.44%
EPS Next Y54.42%
EPS Next 2Y39.52%
EPS Next 3Y38.39%
EPS Next 5Y43.02%
Revenue 1Y (TTM)-47.17%
Revenue growth 3Y-42.02%
Revenue growth 5YN/A
Sales Q2Q%-17.6%
Revenue Next Year34.49%
Revenue Next 2Y51.76%
Revenue Next 3Y49.66%
Revenue Next 5Y52.49%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A